Postoperative follow-up of patients with early breast cancer: Reappraisal of serum tumor markers

Surgery Today

Volumn 32, Issue 1, 2002, Pages 13-18

  Anan, Keisei ^a   Mitsuyama, Shoshu ^a   Tamae, Keiyoshi ^a   Suehara, Nobuhiro ^a   Nishihara, Kazuyoshi ^a   Ogawa, Yoshiaki ^a   Iwashita, Toshimitsu ^a   Abe, Yuji ^a   Ihara, Takaaki ^a   Nakahara, Shosaku ^a   Katsumoto, Fujio ^a   Toyoshima, Satoshi ^a  

^a KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

Author keywords

Asymptomatic; Bone metastasis; Cost effectiveness; NCC ST 439; Tumor polypeptide antigen

Indexed keywords

CARBOHYDRATE ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BONE METASTASIS; BREAST CARCINOMA; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER STAGING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISEASE COURSE; EVALUATION; FOLLOW UP; HUMAN; MAMMOGRAPHY; PATIENT SELECTION; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; THORAX RADIOGRAPHY;

ADULT; AGED; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; REGISTRIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 18244376178     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s595-002-8106-5     Document Type: Article

References (27)

1. The role of bone and liver scans in surveying patients with breast cancer for metastatic disease
2. CA15-3 and bone scintigraphy in the follow-up of breast cancer
3. A minimalist policy for breast cancer surveillance
4. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial
5. Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up
6. Recommended breast cancer surveillance guidelines
7. Demonstration of an iron sensitive antigenic site on carcinoembryonic antigen using zirconyl phosphate gel
8. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors
9. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors
10. Specificity and basis of the tissue polypeptide antigen
11. Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit
12. Serum and immunohistochemical studies of NCC-ST-439 in breast cancer
13. Monoclonal antibody reactive with the sialyl-sugar residue of a high molecular weight glycoprotein in sera of cancer patients
14. Study for clinical usefulness of CEA, TPA, CA15-3 and BCA225 in breast cancer
15. Immunocytochemical distribution of a breast carcinoma associated glycoprotein identified by monoclonal antibodies
16. CA15.3, CEA and TPA tumor markers in the early diagnosis of breast cancer relapse
17. Clinical value of TPS, CEA and CA15-3 in breast cancer patients
18. Clinical value of CA15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients
19. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer
20. 1997 Update of recommendations for the use of tumor markers in breast and colorectal cancer
21. Tumour markers in breast cancer - EGTM recommendations
22. Serum tumor marker kinetics and the clinical course of patients with advanced breast cancer
23. Sandwich radioimmunometric assay with murine monoclonal antibody. NCC-ST-439, for serological diagnosis of human cancers
24. Biochemical markers of bone turnover in breast cancer patients with bone metastases: A preliminary report
25. Serum concentration of pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with metastatic breast cancer
26. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer
27. Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin